Antibiotics Alert Sample


Alert Sample

Alert results for: Antibiotics

Information between 25th March 2024 - 14th April 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Select Committee Documents
Tuesday 9th April 2024
Engagement document - Inquiry into Veterinary Medicines and The Windsor Framework: Roundtable meeting with Northern Ireland based stakeholders, 1 February 2024, Belfast - Note of discussion

Windsor Framework Sub-Committee

Found: The core objective of this w as to actively demonstrate the sector’s reduction in the use of antibiotics

Tuesday 26th March 2024
Oral Evidence - 2024-03-26 10:00:00+00:00

Pharmacy - Health and Social Care Committee

Found: an evaluation commissioned around antimicrobial resistance and looking at the total quantity of antibiotics

Tuesday 26th March 2024
Report - Fifth Report - The prevalence of sexually transmitted infections in young people and other high risk groups

Women and Equalities Committee

Found: gonorrhoea as “one of the most highly drug-resistant organisms we have”, with very few effective antibiotics



Department Publications - Transparency
Friday 12th April 2024
Home Office
Source Page: Non-technical summaries granted in 2024
Document: Non-technical summaries: projects granted in 2024, January to March (PDF)

Found: Appropriate effective treatment e.g. antibiotics will be administered under the advice of the Named



Non-Departmental Publications - Transparency
Apr. 09 2024
Medicines and Healthcare products Regulatory Agency
Source Page: MHRA FOI performance data
Document: (Excel)
Transparency

Found: whether there is any evidence of allergy to ezetimibe in patients with known allergy to beta lactam antibiotics



Non-Departmental Publications - News and Communications
Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: Combined antibiotic approved to treat adult patients with severe infections of the urinary tract and hospital-acquired pneumonia
Document: Combined antibiotic approved to treat adult patients with severe infections of the urinary tract and hospital-acquired pneumonia (webpage)
News and Communications

Found: When infections in the urinary tract or lungs (pneumonia) develop resistance to traditional antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: National Patient Safety Alert: ​​Reducing risks for transfusion-associated circulatory overload​ ​(NatPSA/2024/004/MHRA​)
Document: within TACO chapter (PDF)
News and Communications

Found: received oxygen via continuous positive airway pressure, a diuretic, hydrocortisone, bronchodilator and antibiotics

Mar. 25 2024
Veterinary Medicines Directorate
Source Page: Recruitment for two Non-Executive Directors
Document: Candidate Information Pack (PDF)
News and Communications

Found: VMD), but have you ever: •eaten meat, eggs, fish or honey •drunk milk •owned a pet or animal •taken antibiotics

Mar. 25 2024
Veterinary Medicines Directorate
Source Page: Recruitment for two Non-Executive Directors
Document: Recruitment for two Non-Executive Directors (webpage)
News and Communications

Found: Directorate (VMD), but have you ever: eaten meat, eggs, fish or honey drunk milk owned a pet or animal taken antibiotics



Non-Departmental Publications - Guidance and Regulation
Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: E7 – Studies in Support of Special Populations: Geriatrics (PDF)
Guidance and Regulation

Found: effects of known inhibitors, such as quinidine (for cytochrome P-450 2D6) or ketoconazole and macrolide antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: E10 – Choice of Control Group and Related Issues in Clinical Trials (PDF)
Guidance and Regulation

Found: reasons, and if a defined treatment effect of the active control is regularly seen (e.g., as it is for antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: Q5D – Derivation and Characterisation of Cell Substrates Used for Productions of Biotechnological/Biological Products (PDF)
Guidance and Regulation

Found: cells cultivated from cell banks with the exception of microbial metabolites such as, for example, antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: E17 – General Principles for planning and design of Multi-Regional Clinical Trials (PDF)
Guidance and Regulation

Found: prevalent in a single region (e.g., anti-malarial drugs, vaccines specific to local epidemics, or antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: Q5C – Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products (PDF)
Guidance and Regulation

Found: The document does not cover antibiotics, allergenic extracts, heparins, vitamins, whole blood, or cellular

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: S2(R1) – Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use (PDF)
Guidance and Regulation

Found: Compounds that are Toxic to Bacteria In cases where compounds are highly toxic to bacteria (e.g., some antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: Q1A(R2) – Stability Testing of New Drug Substances and Products (PDF)
Guidance and Regulation

Found: The same may be true for certain antibiotics.

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: S5(R3) – Revision of S5 Guidelines on Detection of Toxicity to Reproduction for Human Pharmaceuticals (PDF)
Guidance and Regulation

Found: fertility and pre -/postnatal studies • Sensitive to gastr ointestinal disturbances; (e.g., some antibiotics

Apr. 04 2024
Medicines and Healthcare products Regulatory Agency
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: S6(R1) – Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals (PDF)
Guidance and Regulation

Found: This document does not cover antibiotics, allergenic extracts, heparin, vitamins, cellular blood components